Predictors of postpartum diabetes in women with gestational diabetes mellitus

Diabetes

Volumn 55, Issue 3, 2006, Pages 792-797

  Löbner, Kristian ^a   Knopff, Annette ^a   Baumgarten, Andrea ^a   Mollenhauer, Ulrike ^a   Marienfeld, Sabine ^a   Garrido Franco, Marta ^a   Bonifacio, Ezio ^a,b   Ziegler, Anette G ^a,c  

^a Klinikum Schwabing   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; GLUCOSE; GLUTAMATE DECARBOXYLASE; INSULIN; INSULINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HAZARD ASSESSMENT; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PARITY; PATIENT SELECTION; POSTPARTUM DIABETES; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE;

EID: 33644773724     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.03.06.db05-0746     Document Type: Article

References (31)

1. American Diabetes Association: Standards of medical care in diabetes. (Position Statement). Diabetes Care 28 (Suppl. 1):S4-S36, 2005
2. Hanna FW, Peters JR: Screening for gestational diabetes; past, present and future. Diabet Med 19:351-358, 2002
3. Ben-Haroush A, Yogev Y, Hod M: Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103-113, 2004
4. O'Sullivan JB: Diabetes mellitus after GDM. Diabetes 40 (Suppl. 2):131-135, 1991
5. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Molsted-Pedersen L, Hornnes P, Locht H, Pedersen O, Damm P: Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27:1194-1199, 2004
6. Fuchtenbusch M, Ferber K, Standl E, Ziegler AG: Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 46:1459-1467, 1997
7. Damm P, Kuhl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F, Shattock M, Bottazzo GF, Molsted-Pedersen L: Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 11:558-563, 1994
8. Ferber KM, Keller E, Albert ED, Ziegler AG: Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 84:2342-2348, 1999
9. Roll U, Christie MR, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG: Perinatal autoimmunity in offspring of diabetic parents: the German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45:967-973, 1996
10. Kuczmarski RJ, Flegal KM: Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72:1074-1081, 2000
11. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600, 2002
12. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
13. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162:82-89, 2002
14. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L, Tuomi T: Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54:166-174, 2005
15. Aberg AE, Jonsson EK, Eskilsson I, Landin-Olsson M, Frid AH: Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 81:11-16, 2002
16. Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7, 2004
17. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000
18. Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, Haffner SM: Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108:1822-1830, 2003
19. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV: Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 27:2033-2040, 2004
20. Ridker PM, Wilson PW, Grundy SM: Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818-2825, 2004
21. Chase HP, Cooper S, Osberg I, Stene LC, Barriga K, Norris J, Eisenbarth GS, Rewers M: Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 53:2569-2573, 2004
22. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
23. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
24. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
25. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
26. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
27. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796-2803, 2002
28. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155-161, 2004
29. Xiang AH, Peters RK, Kjos SL, Goico J, Ochoa C, Marroquin A, Tan S, Hodis HN, Azen SP, Buchanan TA: Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab 89:2846-2851, 2004
30. Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA, Walker EA, Fowler SE, Nathan DM, Kahn SE, the Diabetes Prevention Program Research Group: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 54:1150-1156, 2005
31. Azen SP, Peters RK, Berkowitz K, Kjos S, Xiang A, Buchanan TA: TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebocontrolled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials 19:217-231, 1998